✦ LIBER ✦

Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis

✍ Scribed by Sanaa M. Kamal; Bradley Turner; Qi He; Jens Rasenack; Leonardo Bianchi; Ahmed Al Tawil; Ahmed Nooman; Mahmoud Massoud; Margaret James Koziel; Nezam H. Afdhal

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 480 KB
Volume: 43
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.21117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship of serum fibrosis markers w

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

✍ Robert J. Fontana; Zachary D. Goodman; Jules L. Dienstag; Herbert L. Bonkovsky; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

This study determined the utility of a panel of serum fibrosis markers along with routine laboratory tests in estimating the likelihood of histological cirrhosis in a cohort of prior nonresponders with chronic hepatitis C. The relationship between serum markers and quantitative hepatic collagen cont

Steatosis and progression of fibrosis in

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection

✍ Ponni Perumalswami; David E. Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path

Impact of steatosis on progression of fi

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C

✍ Laetitia Fartoux; Olivier Chazouillères; Dominique Wendum; Raoul Poupon; Lawrenc 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

In patients with mild hepatitis C, the usefulness of antiviral therapy is subject of debate, as a low risk for progression of fibrosis is assumed. Several studies have shown that steatosis is a strong and independent predictor of the severity as well as the progression of fibrosis in chronic hepatit

Progression of liver fibrosis among inje

Progression of liver fibrosis among injection drug users with chronic hepatitis C

✍ Lucy E. Wilson; Michael Torbenson; Jacquie Astemborski; Hawazin Faruki; Charles 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Although most hepatitis C virus (HCV) infections are acquired by injection drug use, prospective data on the progression of liver fibrosis are sparse. Baseline liver biopsies were obtained (1996-1998) on a random sample of 210 out of 1667 HCV-positive injection drug users (IDUs). Subjects were follo

HLA class I allelic diversity and progre

HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C

✍ Keyur Patel; Suzanne Norris; Lauralynn Lebeck; Anne Feng; Michael Clare; Stephen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Patients infected with HIV-1 who are heterozygous at HLA class I loci present greater variety of antigenic peptides to CD8+ cytotoxic T lymphocytes, slowing progression to AIDS. A similar broad immune response in chronic hepatitis C (CHC) infection could result in greater hepatic injury. Although sp

Human platelet antigen genotype is assoc

Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C

✍ Giovanni Faria Silva; Rejane Maria Tommasini Grotto; Camila Fernanda Verdichio-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract Although progression of fibrosis in the chronic hepatitis C depends on environmental, viral, and host factors, genetic polymorphisms have been associated recently with this progression, including the expression of integrins, adhesion proteins. Some integrins expressed on the platelet me